Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-016905
Filing Date
2015-02-20
Accepted
2015-02-20 18:34:38
Documents
1
Period of Report
2015-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5559
  Complete submission text file 0001209191-15-016905.txt   7120
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
FRACTOR DAVID (Reporting) CIK: 0001215025 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35560 | Film No.: 15637152